News | February 14, 2022
Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
It is being developed by Pune-based Gennova Biopharmaceuticals
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
_256_384.jpg){kind=logo}
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe
In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three
NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction
Granules India has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
